SEC Form 3 · accession 0001209191-17-039162
CRESCENT BIOPHARMA, INC. · CBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patricia S Andrews
Director
Period of report
Jun 9, 2017
Accepted (ET)
Jun 12, 2017 · 4:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001253689
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| No securities beneficially owned | holding | — | — | — | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Exhibit 24.1 - Power of Attorney